Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - LONG-TERM DEBT
Long-term Debt REGN - Regeneron Pharmaceuticals, Inc.
2.7 B
LAST VALUE
0.06%
2 YEAR CAGR
30.52%
5 YEAR CAGR
19.44%
10 YEAR CAGR